+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vivus - logo

VIVUS is a biopharmaceutical company that develops and commercializes therapies to address unmet medical needs in the United States and the European Union. The company’s lead product Qsymia is a combination appetite suppressant/stimulant and seizure medication indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in overweight and obese adults. VIVUS was founded in 1991 and is headquartered in Campbell, California.

Global Market for Anti-obesity Drugs - Product Thumbnail Image

Global Market for Anti-obesity Drugs

  • Report
  • November 2023
  • 67 Pages
  • Global
From
Anti-Obesity Drugs: Global Strategic Business Report - Product Thumbnail Image

Anti-Obesity Drugs: Global Strategic Business Report

  • Report
  • February 2024
  • 264 Pages
  • Global
From
From
Global Anti-obesity Drugs Market 2023-2027 - Product Thumbnail Image

Global Anti-obesity Drugs Market 2023-2027

  • Report
  • November 2022
  • 120 Pages
  • Global
From
Antiobesity Global Market Report 2024 - Product Thumbnail Image

Antiobesity Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
From
From
Loading Indicator